<DOC>
	<DOC>NCT01337830</DOC>
	<brief_summary>Study to determine the safety and effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers.</brief_summary>
	<brief_title>Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers</brief_title>
	<detailed_description>Each subject will be given an Ariva® Silver Wintergreen lozenge or a Silver Wintergreen lozenge, which contains only silver salt, on a random basis. Once the lozenge has dissolved in the mouth, subjects will smoke one of their own cigarettes, and will answer questions about the experience and their craving for a cigarette. After a washout period, each subject will repeat the steps with the second type of lozenge.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>healthy adult smoker smoking for at least 5 years smoking at least one (1) pack of cigarettes a day interest in quitting smoking known allergy to silver or silver salts pregnant or breastfeeding current drug or alcohol abuse, and/or history of drug or alcohol dependence within 3 months of study</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>smoking</keyword>
	<keyword>smokeless</keyword>
	<keyword>aversion</keyword>
	<keyword>nicotine</keyword>
	<keyword>nicotine replacement</keyword>
</DOC>